# 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate

> **NCT00429338** · NA · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** AIR-MRSI
- **PROCEDURE:** PFC-MRSI

## Key facts

- **NCT ID:** NCT00429338
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2015-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429338, "3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00429338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*